Connect Biopharma Holdings Limited
CNTB
$0.7901
-$0.0099-1.24%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 26.41% | 26.41% | 125.10% | 125.10% | 47.20% |
| Total Depreciation and Amortization | -13.62% | -13.62% | -6.11% | -6.11% | -61.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 64.84% | 64.84% | 146.15% | 146.15% | -51.18% |
| Change in Net Operating Assets | -79.60% | -79.60% | -833.77% | -833.77% | 877.81% |
| Cash from Operations | 5.72% | 5.72% | 74.41% | 74.41% | 68.02% |
| Capital Expenditure | -250.96% | -250.96% | -50.87% | -50.87% | 107.51% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -137.89% | -137.89% | -63.02% | -63.02% | 432.43% |
| Cash from Investing | -138.46% | -138.46% | -63.98% | -63.98% | 372.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 2.78% | 2.78% | -2.78% | -2.78% | 199.17% |
| Issuance of Common Stock | 443.48% | 443.48% | 363.64% | 363.64% | -15.44% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 63.47% | 63.47% | 62.30% | 62.30% | 241.53% |
| Foreign Exchange rate Adjustments | -41.85% | -41.85% | 57.55% | 57.55% | 96.98% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -231.02% | -231.02% | 60.33% | 60.33% | 130.61% |